Following a technical consultation held between the World Health Organization (WHO) and the United States Centers for Disease Control and Prevention (CDC) in Atlanta, GA, in September 2008 on strategies, approaches and partnerships that could be implemented to improve laboratory biosafety worldwide, an Expert Group meeting was convened at WHO’s Headquarters in Geneva, Switzerland, in April 2009 to elaborate guidance on biosafety related to laboratory procedures for diagnosing
tuberculosis (TB). The purpose of the meeting was to reach consensus on the basic principles of laboratory practices and design necessary to establish minimum criteria to ensure biosafety during TB microscopy, culture, drug-susceptibility testing (DST) and molecular testing in different countries and epidemiological settings.
This manual was developed from the Expert Group meeting and was approved by WHO’s Guidelines Review Committee in May 2012. It is intended to inform rather than replace country-level requirements and standards for biosafety. The recommendations do not supersede any local or national rules or regulations.
Download the manual from here.
Source: Global Laboratory Initiative